Extension of quality-by-design concept to the early development phase of pharmaceutical R&D processes
Here, we propose the extension of the quality-by-design (QbD) concept to also fit the early development phases of pharmaceuticals by adding elements that are currently widely applied, but not yet included in the QbD model in a structured way. These are the introduction of a ‘zero’ preformulation...
Elmentve itt :
| Szerzők: | |
|---|---|
| Dokumentumtípus: | Cikk |
| Megjelent: |
2018
|
| Sorozat: | DRUG DISCOVERY TODAY
23 No. 7 |
| doi: | 10.1016/j.drudis.2018.03.012 |
| mtmt: | 3356511 |
| Online Access: | http://publicatio.bibl.u-szeged.hu/14514 |